Medroxyprogesterone Acetate | GMP-Certified USP/EP Grade Hormone API 💊
Contraceptive & Oncology Applications with ≥99% Purity
📌 Product Overview
Medroxyprogesterone Acetate is a synthetic progestin widely used in hormonal contraceptives, oncology therapies, and hormone replacement treatments12. It regulates progesterone receptors to inhibit ovulation and suppress estrogen-dependent tumor growth14. Suitable for oral tablets, injectables, and implantable devices, it meets pharmaceutical-grade standards for precision and safety12.
✅ Key Advantages
| 🔥 Feature | 📈 Specification/Effect |
|---|
| ≥99% HPLC Purity | Complies with USP/EP pharmacopeia standards12 |
| Stable Formulation | Maintains potency for 24 months under controlled storage14 |
| Low Residual Solvents | ≤10 ppm (ICH Q3C compliant)12 |
| Non-GMO & Halal Certified | Global regulatory compliance for diverse markets24 |
🌍 Applications
- Contraceptives
: Long-acting injectables (e.g., Depo-Provera®) and oral formulations14.
- Oncology
: Adjunctive therapy for endometrial and renal cancers24.
- Gynecological Disorders
: Treatment of endometriosis and abnormal uterine bleeding12.
- Hormone Replacement Therapy (HRT)
: Menopause symptom management14.
📜 Quality Certifications
Manufactured under GMP, ISO 9001, and WHO guidelines .
Tested via HPLC, GC-MS, and residual solvent analysis.
Compliant with FDA 21 CFRand EU GMP Annex 1.
📈 Market Trends
The global hormonal contraceptives market is projected to reach $23.7B by 2030, driven by rising demand for long-acting reversible contraceptives24. Oncology applications of progestins are growing at 6.8% CAGR, supported by advancements in targeted cancer therapies14.
China
